The facility - where Innovus Pharma supplements including UriVArx® are manufactured - is registered with NSF International and is in compliance with Current Good Manufacturing Practice (CGMP). These guidelines define the manufacturing processes, procedures, and documentation that assure the identity, strength, composition, and quality of the product.

The leading U.S. and international academic and clinical physicians, Key Opinion Leaders, and scientists of Innovus Pharma Medical and Clinical Advisory Boards meet to oversee the clinical trials, research, and all product formulations. We are continuously monitoring responses and any side effect by customers to address and improve our formulations. For more info on our Medical and Clinical Advisory Boards, please visit our corporate website at